Vaxcyte Shares Sold by Aquatic Capital Management

Institutional investor reduces stake in biotech company

Mar. 17, 2026 at 7:24am

Got story updates? Submit your updates here. ›

Aquatic Capital Management LLC lowered its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX) by 39.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 125,785 shares of the company's stock after selling 80,386 shares.

Why it matters

Vaxcyte is a clinical-stage biotech company focused on developing a new generation of preventive vaccines. The sale of a significant portion of Aquatic Capital's stake in the company could signal a shift in investor sentiment or a reallocation of funds, which could impact Vaxcyte's operations and future prospects.

The details

Aquatic Capital Management LLC sold 80,386 shares of Vaxcyte, reducing its total holdings to 125,785 shares. The institutional investor now owns approximately 0.10% of Vaxcyte's outstanding shares. The sale comes as Vaxcyte continues to advance its lead candidate, VAX-24, a 24-valent pneumococcal conjugate vaccine.

  • Aquatic Capital Management LLC lowered its holdings in Vaxcyte during the third quarter of 2026.

The players

Aquatic Capital Management LLC

An institutional investor that previously held a stake in Vaxcyte, Inc.

Vaxcyte, Inc.

A clinical-stage biotechnology company focused on developing a new generation of preventive vaccines.

Got photos? Submit your photos here. ›

The takeaway

The sale of a significant portion of Aquatic Capital's stake in Vaxcyte could signal a shift in investor sentiment towards the biotech company, which may impact its future operations and development of its pipeline of preventive vaccines.